ArticleBMJ open2025

The effectiveness and risks of Treating people with Idiopathic Pulmonary fibrosis with the Addition of Lansoprazole (TIPAL): study protocol for a randomised placebo-controlled multicentre clinical trial.

Megan Jones et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.